WATSON 698 200 (Hydroxychloroquine Sulfate 200 mg)

Pill with imprint WATSON 698 200 is White, Elliptical / Oval and has been identified as Hydroxychloroquine Sulfate 200 mg. It is supplied by Actavis Pharma, Inc..

Hydroxychloroquine is used in the treatment of rheumatoid arthritis; systemic lupus erythematosus; lyme disease, arthritis; dermatomyositis; malaria (and more), and belongs to the drug classes antimalarial quinolines, antirheumatics. FDA has not classified the drug for risk during pregnancy. Hydroxychloroquine 200 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for WATSON 698 200

Hydroxychloroquine Sulfate

Imprint:

WATSON 698 200

Strength:

200 mg

Color:

White

Size:

13.00 mm

Shape:

Elliptical / Oval

Availability:

Prescription only

Drug Class:

Antimalarial quinolines
Antirheumatics

Pregnancy Category:

N - Not classified

CSA Schedule:

Not a controlled drug

Labeler / Supplier:

Actavis Pharma, Inc.

Inactive Ingredients:

silicon dioxide
dextrates
magnesium stearate
maltodextrin
microcrystalline cellulose
polydextrose
polyethylene glycol 8000
sodium starch glycolate type A potato
corn starch
titanium dioxide
triacetin
hypromellose 2910 (3 mPa.s)
hypromellose 2910 (6 mPa.s)
hypromellose 2910 (50 mPa.s)
Note: Inactive ingredients may vary.

Other Labelers / Repackagers:

NDC Code	Labeler / Repackager
00591-0698	Watson Pharmaceuticals, Inc.

More Info Imprint SearchPrint

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer